199 related articles for article (PubMed ID: 21998658)
1. 3'UTR-mediated gene silencing of the Mixed Lineage Leukemia (MLL) gene.
Gomez-Benito M; Loayza-Puch F; Oude Vrielink JA; Odero MD; Agami R
PLoS One; 2011; 6(10):e25449. PubMed ID: 21998658
[TBL] [Abstract][Full Text] [Related]
2. DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia.
Chen CW; Koche RP; Sinha AU; Deshpande AJ; Zhu N; Eng R; Doench JG; Xu H; Chu SH; Qi J; Wang X; Delaney C; Bernt KM; Root DE; Hahn WC; Bradner JE; Armstrong SA
Nat Med; 2015 Apr; 21(4):335-43. PubMed ID: 25822366
[TBL] [Abstract][Full Text] [Related]
3. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
[TBL] [Abstract][Full Text] [Related]
4. MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Carrillo E; Sánchez J; Pérez-López O; Pérez de Soto I; González Campos J; Prats-Martín C; Bernal R; Vargas MT
Eur J Haematol; 2018 May; 100(5):436-443. PubMed ID: 29384595
[TBL] [Abstract][Full Text] [Related]
5. Translational regulation of GluR2 mRNAs in rat hippocampus by alternative 3' untranslated regions.
Irier HA; Shaw R; Lau A; Feng Y; Dingledine R
J Neurochem; 2009 Apr; 109(2):584-94. PubMed ID: 19222700
[TBL] [Abstract][Full Text] [Related]
6. MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome.
Wang QF; Wu G; Mi S; He F; Wu J; Dong J; Luo RT; Mattison R; Kaberlein JJ; Prabhakar S; Ji H; Thirman MJ
Blood; 2011 Jun; 117(25):6895-905. PubMed ID: 21518926
[TBL] [Abstract][Full Text] [Related]
7. Regulation of AGR2 expression via 3'UTR shortening.
Matoulkova E; Sommerova L; Pastorek M; Vojtesek B; Hrstka R
Exp Cell Res; 2017 Jul; 356(1):40-47. PubMed ID: 28408318
[TBL] [Abstract][Full Text] [Related]
8. Distinct expression of select and transcriptome-wide isolated 3'UTRs suggests critical roles in development and transition states.
Ji S; Yang Z; Gozali L; Kenney T; Kocabas A; Jinsook Park C; Hynes M
PLoS One; 2021; 16(5):e0250669. PubMed ID: 33951080
[TBL] [Abstract][Full Text] [Related]
9. Endogenous p53 expression in human and mouse is not regulated by its 3'UTR.
Mitschka S; Mayr C
Elife; 2021 May; 10():. PubMed ID: 33955355
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel biomarkers for MLL-translocated acute myeloid leukemia.
Lagacé K; Barabé F; Hébert J; Cellot S; Wilhelm BT
Exp Hematol; 2017 Dec; 56():58-63. PubMed ID: 28911906
[TBL] [Abstract][Full Text] [Related]
11. A novel extended form of alpha-synuclein 3'UTR in the human brain.
Je G; Guhathakurta S; Yun SP; Ko HS; Kim YS
Mol Brain; 2018 May; 11(1):29. PubMed ID: 29801501
[TBL] [Abstract][Full Text] [Related]
12. Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in acute myeloid leukemia.
Röhrs S; Dirks WG; Meyer C; Marschalek R; Scherr M; Slany R; Wallace A; Drexler HG; Quentmeier H
Mol Cancer; 2009 Oct; 8():86. PubMed ID: 19835597
[TBL] [Abstract][Full Text] [Related]
13. Maternal 3'UTRs: from egg to onset of zygotic transcription in Atlantic cod.
Kleppe L; Edvardsen RB; Kuhl H; Malde K; Furmanek T; Drivenes O; Reinhardt R; Taranger GL; Wargelius A
BMC Genomics; 2012 Sep; 13():443. PubMed ID: 22937762
[TBL] [Abstract][Full Text] [Related]
14. MLL fusions: pathways to leukemia.
Liu H; Cheng EH; Hsieh JJ
Cancer Biol Ther; 2009 Jul; 8(13):1204-11. PubMed ID: 19729989
[TBL] [Abstract][Full Text] [Related]
15. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations.
Drexler HG; Quentmeier H; MacLeod RA
Leukemia; 2004 Feb; 18(2):227-32. PubMed ID: 14671638
[TBL] [Abstract][Full Text] [Related]
16. Targeted Next-Generation Sequencing for Detecting
Afrin S; Zhang CRC; Meyer C; Stinson CL; Pham T; Bruxner TJC; Venn NC; Trahair TN; Sutton R; Marschalek R; Fink JL; Moore AS
Mol Cancer Res; 2018 Feb; 16(2):279-285. PubMed ID: 29133595
[TBL] [Abstract][Full Text] [Related]
17. The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.
Zheng L; Li X; Gu Y; Lv X; Xi T
Breast Cancer Res Treat; 2015 Feb; 150(1):105-18. PubMed ID: 25701119
[TBL] [Abstract][Full Text] [Related]
18. Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia.
Brzezinka K; Nevedomskaya E; Lesche R; Steckel M; Eheim AL; Haegebarth A; Stresemann C
J Hematol Oncol; 2019 Jun; 12(1):66. PubMed ID: 31253180
[TBL] [Abstract][Full Text] [Related]
19. Differential evolution in 3'UTRs leads to specific gene expression in Staphylococcus.
Menendez-Gil P; Caballero CJ; Catalan-Moreno A; Irurzun N; Barrio-Hernandez I; Caldelari I; Toledo-Arana A
Nucleic Acids Res; 2020 Mar; 48(5):2544-2563. PubMed ID: 32016395
[TBL] [Abstract][Full Text] [Related]
20. The molecular biology of mixed lineage leukemia.
Slany RK
Haematologica; 2009 Jul; 94(7):984-93. PubMed ID: 19535349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
